Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
48,809,163
-
Total 13F shares
-
32,270,574
-
Share change
-
-426,078
-
Total reported value
-
$183,952,552
-
Put/Call ratio
-
138%
-
Price per share
-
$5.70
-
Number of holders
-
161
-
Value change
-
-$9,250,058
-
Number of buys
-
75
-
Number of sells
-
58
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) as of Q1 2025
As of 31 Mar 2025,
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,270,574 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Anchorage Capital Group, L.L.C., Erste Asset Management GmbH, EcoR1 Capital, LLC, MILLENNIUM MANAGEMENT LLC, Legal & General Group Plc, BlackRock, Inc., and Opaleye Management Inc..
This page lists
161
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.